Drug Safety Matters

#24 A week in the name of medicines safety – part 1

November 02, 2023 Uppsala Monitoring Centre
Drug Safety Matters
#24 A week in the name of medicines safety – part 1
Show Notes Chapter Markers

To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.

Tune in to find out:

  • Why under-reporting plagues all pharmacovigilance systems
  • What regulators can do to encourage people to report side effects
  • Why we need reports from both patients and healthcare professionals

Want to know more?

 Here are the studies cited in the episode:

  • A BMJ study in 2022 measured the burden and associated cost of adverse drug reactions, polypharmacy and multimorbidity at a hospital in the UK.
  • In 1976, Inman proposed a theoretical model, known as the ‘seven deadly sins’, to explain why healthcare professionals fail to report adverse drug reactions. This recent systematic review in Drug Safety expands on that. 
  • The SCOPE Joint Action project aimed to enhance pharmacovigilance in the EU and delivered practical guidance for regulators.
  • The first UK study to compare Yellow Card reports from patients and healthcare professionals was published in 2012.

To join the #MedSafetyWeek campaign next week, follow the hashtag online and check out the campaign website for free social media materials.

Finally, don’t forget to tune in on 13 November for part 2 of this podcast, where we’ll hear from #MedSafetyWeek advocates in Iraq, Luxembourg, and Namibia about their experience with the campaign. Read a preview of the conversation on Uppsala Reports.

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.

Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!

About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.

Welcome, Mitul!
Why we need communications campaigns
Barriers to reporting
Different reporters, different perspectives
Other interventions to prompt reporting
Global versus local
Future of #MedSafetyWeek